|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$902,101
|
$180,420
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-02
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$75,588
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
5R37CA071692-13
|
$348,711
|
$348,711
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$20,702
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-09
|
$1,961,166
|
$431,457
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
VITAMIN D PLANT ANTIOXIDANT SILIBININ IN LEUKEMIA TRANSLATIONAL STUDY
|
5R01CA117942-03
|
$189,600
|
$189,600
|
STUDZINSKI, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy
|
5R01CA044722-19
|
$205,937
|
$205,937
|
STUDZINSKI, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$4,310
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$9,449
|
McGlynn
|
DCEG (NCI)
|
|
VEGF Function in B-CLL
|
5R01CA116237-04
|
$268,755
|
$268,755
|
Kay, Neil
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$2,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$6,283
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
1R01CA140292-01
|
$357,937
|
$357,937
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
1P50CA136411-01A1
|
$500,000
|
$115,000
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
2U01CA105492-06
|
$742,917
|
$252,592
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-05
|
$320,964
|
$109,128
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S1
|
$74,165
|
$4,450
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S2
|
$100,000
|
$6,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-34
|
$6,658,653
|
$399,519
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$18,843
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-07
|
$1,664,784
|
$332,957
|
FRONTERA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-07
|
$1,119,031
|
$223,806
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
3P50CA100632-07S1
|
$52,857
|
$52,857
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-07
|
$2,300,000
|
$2,300,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$12,153
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$274,276
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-22
|
$83,653
|
$6,692
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$240,008
|
$96,003
|
Fowler, Daniel
|
CCR (NCI)
|
|
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
|
5R01CA115398-03
|
$223,440
|
$111,720
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-04
|
$290,571
|
$290,571
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-06
|
$215,937
|
$17,275
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor Cell Biology Training Program
|
5T32CA009361-29
|
$704,512
|
$70,451
|
STILES, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Tumor Cell Biology Training Program
|
5T32CA009056-34
|
$491,242
|
$147,373
|
FOX, CHARLES
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-05
|
$1,093,403
|
$109,340
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Treatment of Infections in Immunocompromised Children
|
ZIA SC 006830
|
$1,779,353
|
$1,245,547
|
Walsh, Thomas
|
CCR (NCI)
|
|
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
|
5R01CA090321-08
|
$266,679
|
$266,679
|
HEISTERKAMP, NORA
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Transplantation of G-CSF Stimulated Marrow vs Blood
|
5R01CA108752-04
|
$41,479
|
$41,479
|
Schultz, KIRK
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
Transplant Models
|
ZIA BC 010957
|
$1,010,208
|
$505,104
|
Gress, Ronald
|
CCR (NCI)
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-13
|
$310,254
|
$310,254
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia
|
4R00CA131503-02
|
$249,000
|
$249,000
|
Steidl, Ulrich
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Transcriptional Regulation by the HTLV-1 Tax Protein
|
2R01CA055035-15A2
|
$300,951
|
$300,951
|
NYBORG, JENNIFER
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Transcriptional Deregulation by MLL Fusion Proteins
|
5R01CA092251-09
|
$269,485
|
$269,485
|
Hess, Jay
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transcription Factor Reporter Technology
|
5R33CA134385-02
|
$338,092
|
$111,570
|
Bogdanov, Alexei
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Training Program in Cancer Therapeutics
|
5T32CA117846-04
|
$316,191
|
$63,238
|
WALTZ, SUSAN
|
UNIVERSITY OF CINCINNATI
|
|
Toward Defining the Functional Methylome in Acute Lymphoblastic Leukemia
|
1K99CA132784-01A1
|
$113,213
|
$113,213
|
TAYLOR, KRISTEN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
Total Synthesis of Anticancer Agents Superstolides A & B
|
5R01CA109208-03
|
$257,514
|
$64,379
|
JIN, ZHENDONG
|
UNIVERSITY OF IOWA
|
|
Topoisomerase ll Beta in Myeloid Differentiation by Retionids
|
5R01CA117928-04
|
$266,285
|
$266,285
|
GANAPATHI, RAM
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Topoisomerase I Inhibitors in Leukemia and Solid Tumors
|
5R01CA073709-11
|
$221,813
|
$110,907
|
KAUFMANN, SCOTT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-26
|
$841,858
|
$16,837
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
Total relevant funding to Leukemia for this search: $220,577,770
|